(Q43975579)

28 November 2017

Acute heart failure: determinants of outcome (English)

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

27 November 2022

4

A. J. Esterman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791090

27 November 2022

author name string

P. Mohan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791090

27 November 2022

J. T. Hii

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791090

27 November 2022

R. D. Wuttke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791090

27 November 2022

P. Hollington

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791090

27 November 2022

J. D. Horowitz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1791090

27 November 2022

language of work or name

English

0 references

publication date

1 September 1991

1 reference

full work available at URL

28 November 2017

https://api.elsevier.com/content/article/PII:016752739190300E?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

https://api.elsevier.com/content/article/PII:016752739190300E?httpAccept=text/plain

27 November 2022

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

International Journal of Cardiology

27 November 2022

published in

1 reference

28 November 2017

32

1 reference

28 November 2017

3

1 reference

28 November 2017

365-375

1 reference

Potential for altering the natural history of congestive heart failure: need for large clinical trials

28 November 2017

2

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

27 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

27 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

27 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Epidemiology of congestive heart failure

27 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

27 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy

27 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.

27 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Determinants of clinical response and survival in patients with congestive heart failure treated with captopril

27 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics

27 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Factors influencing the one-year mortality of dilated cardiomyopathy.

27 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation

27 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Factors influencing survival and mode of death in severe chronic ischaemic cardiac failure

27 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity

27 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Correlates and prognostic implication of exercise capacity in chronic congestive heart failure

27 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography

27 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy

27 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

27 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure

27 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease

27 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Acute pulmonary edema due to ischemic heart disease without accompanying myocardial infarction. Natural history and clinical profile

27 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Prognosis of patients with acute pulmonary edema and normal ejection fraction after acute myocardial infarction

27 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Acute cardiogenic pulmonary edema in the elderly: factors predicting in-hospital and one-year mortality

27 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Prognostic factors in acute pulmonary edema

27 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

The prevalence of congestive heart failure in two rural communities

27 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure

27 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Prognosis of congestive heart failure and predictors of mortality

27 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Ventricular arrhythmias during exercise in patients with heart failure: the effect of amiodarone

27 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension

27 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure

27 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study

27 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Placebo-controlled study of lisinopril in congestive heart failure: a multicentre study

27 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study

27 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

27 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure

27 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure

27 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Captopril in heart failure. A double blind controlled trial

27 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state

27 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Captopril therapy for heart failure. A placebo controlled study.

27 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure

27 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

A controlled trial of digoxin in congestive heart failure

27 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

27 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

Patterns of myocardial fibrosis

27 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0167-5273(91)90300-E

27 November 2022

Identifiers

1 reference

28 November 2017

1 reference